Psychedelic retreat marketing starts from a harder place than almost any category in healthcare: there is no paid channel to buy. Psilocybin and ibogaine are Schedule I substances under United States federal law, and Google and Meta both prohibit advertising controlled substances outright. It does not matter that the retreat operates legally in Mexico, Costa Rica, Jamaica or the Netherlands, or that the guest travels there voluntarily. The ad account is reviewed under the platform's policy, not the destination's law, and retreats that try to slip through with vague wellness language either fail review or get an account disabled.
That leaves search, and search turns out to suit this category well. Nobody books a retreat impulsively. The research cycle runs weeks to months, and it is made of long, specific, deeply anxious queries: whether the substance is legal where the retreat operates, what the screening process involves, what the medical contraindications are, what actually happens across the days, what it costs, and whether anyone has been harmed. Those searches are almost entirely unclaimed, because most retreat sites publish an atmospheric homepage, a schedule and a booking form, and answer none of it.
So the work is content that a sceptical reader — often a family member rather than the guest — cannot poke a hole in. Medical screening explained honestly, facilitators named with real credentials, the legal position of the jurisdiction stated plainly, integration described rather than implied, and pricing that is not hidden behind an application. Reviews and first-hand accounts carry more weight here than in any category we work in. Underneath it, tracking to the qualified application rather than the enquiry, because a retreat with a small number of high-value places needs to know which page produced the guest who actually came.